Immune checkpoint inhibitor-associated eosinophilic fasciitis: A FAERS pharmacovigilance analysis of a rare rheumatic immune-related adverse event

Seminars in Arthritis and Rheumatism · Published 2026-07-07 · DOI 10.1016/j.semarthrit.2026.153042

Authors (2)

Ze Wang, Hui Guo

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Wang, Z., Guo, H. (2026). Immune checkpoint inhibitor-associated eosinophilic fasciitis: A FAERS pharmacovigilance analysis of a rare rheumatic immune-related adverse event. Seminars in Arthritis and Rheumatism. https://doi.org/10.1016/j.semarthrit.2026.153042

Related articles

• Interstitial lung disease in mixed connective tissue disease: Insights from an electronic health record-based retrospective cohort study · Seminars in Arthritis and Rheumatism · 2026 · Same journal
• Adherence to dietary recommendations and the risk of developing giant cell arteritis: A nested Case-Control study · Seminars in Arthritis and Rheumatism · 2026 · Same journal
• The association between residual disease and the risk of future disease flares in axial spondyloarthritis: A longitudinal study · Seminars in Arthritis and Rheumatism · 2026 · Same journal
• Paraproteinemias in Sjögren disease: cryoglobulinemia and serum monoclonal gammopathy identify distinct clinical phenotypes and differential lymphoma susceptibility · Seminars in Arthritis and Rheumatism · 2026 · Same journal
• Gender influence on ultrasound-assessed therapeutic response in rheumatoid arthritis: Insights from the GENder on UltraSound (GENUS) study · Seminars in Arthritis and Rheumatism · 2026 · Same journal
• MRI and Ultrasound in giant cell arteritis: complementary strengths and combined diagnostic value · Seminars in Arthritis and Rheumatism · 2026 · Same journal
• Understanding patient and physician global assessments in rheumatoid arthritis: A meta-epidemiological study of core outcome set performance · Seminars in Arthritis and Rheumatism · 2026 · Same journal
• Suitability of the Oxford Shoulder Score for measuring pain in clinical trials evaluating interventions for people with shoulder disorders according to the OMERACT filter 2.2 · Seminars in Arthritis and Rheumatism · 2026 · Same journal
• Risk of second primary cancer and death in patients with idiopathic inflammatory myopathies · Seminars in Arthritis and Rheumatism · 2026 · Same journal
• Development of a single‑item patient‑reported measure of treatment side‑effect burden in clinical trials of rheumatic and musculoskeletal diseases using stakeholder input and large language model refinement · Seminars in Arthritis and Rheumatism · 2026 · Same journal